TABLE 1.

Baseline clinical data and status of OCT biomarkers.

Baseline clinical data	50 patients, 64 eyes
Age	66.22 ± 10.17
Gender (female)	30/50 (60.0%)
Lens (pseudophakic)	26/64 (40.6%)
Side (OD)	30/64 (46.9%)
HbA1c	7.47 ± 1.34
CRTinitial	411.17 ± 119.50
LogMARinitial	0.81 ± 0.46
IOPinitial	15.66 ± 3.40
s/p IVI	27/64 (42.2%)
s/p PST	28/64 (43.8%)
s/p PRP	37/64 (57.8%)
Follow-up months
3	5/64 (7.8%)
6	15/64 (23.4%)
12	44/64 (68.8%)
Mean	9.89 ± 3.24
Injection times
1	21/64 (32.8%)
2	23/64 (35.9%)
3	20/64 (31.3%)
Mean	1.98 ± 0.81